Analyse @AlbertBourla's tweets
@AlbertBourla
| 58,583 followers
Very proud of both our Q3 financial results & the strong foundation we have built for growth. From RSV, to UC, to migraines—and more, we expect to launch up to 19 new products or indications in the next 18mos to help address a range of patient needs: https://t.co/9cn6cZl7W1 $PFE